Getting Through the Noise: Communication Strategy Across the Life Sciences Stakeholder Journey
This is the fourth post in a five-part series — What 19 Product Launches Taught Me.
Post 1:What 19 Product Launches Taught Me
Post 2: Know Your Customer Better Than They Know Themselves
Post 3: The Price Is The Strategy
The communication environment in life sciences has changed fundamentally. Traditional advertising was unidirectional — the organization sent a message, the audience received it, and the transaction ended there. Digital advertising made it bidirectional — the customer could respond, and the response became data. Social platforms transformed it into a network — customers receive messages from organizations and then have conversations with each other about what they received, conversations the organization can observe but not control.
The practical consequence of this evolution is significant: brand meaning in life sciences now depends more on what physicians, patients, and payers communicate to each other than on what the organization communicates to them. A Key Opinion Leader's published case series, a patient advocacy group's treatment guidance, a formulary committee's coverage decision — each of these communicates something about the product that the organization's promotional budget cannot override. The question is not whether this peer-to-peer communication will happen. It will. The question is whether the organization has built the conditions under which it will happen in the product's favor.
In a market where every prescriber, payer, and patient is bombarded by competing messages from every direction — and where AI-generated content has compressed the signal-to-noise ratio to near zero — the question is not how much to communicate or how loudly. It is how precisely.
Brand meaning now depends more on what stakeholders communicate to each other than on what the organization communicates to them. The promotional budget does not override peer conversation. It shapes the conditions under which peer conversation happens.
Three Motives, Five Stages: The Architecture of Stakeholder Communication
Every communication act in a commercial strategy serves one of three motives — Inform, Persuade, or Remind — and its effectiveness depends entirely on whether the motive matches the stage of the stakeholder's decision-making process.
Inform — makes consumers aware of the product's existence and its benefits. It is the appropriate motive at the point of need recognition — when the stakeholder does not yet know the product exists, does not understand the problem it solves, or does not recognize the gap between the current standard of care and what is now possible. Informing a stakeholder who is already aware and evaluating alternatives is not communication — it is noise.
Persuade — turns consumer awareness into a want — converting the recognized need into a preference for the specific product. It is the appropriate motive during information search and the evaluation of alternatives, when the stakeholder knows the product exists and is deciding whether it is the right choice. Persuasion that arrives before awareness has been established is premature. Persuasion that arrives after the adoption decision has been made is wasted.
Remind — reinforces brand meaning to build loyalty and retain customers who have already adopted the product. It is the appropriate motive post-purchase — maintaining the prescriber's confidence, reinforcing the patient's adherence, and building the advocacy infrastructure that drives peer recommendation. Organizations that invest heavily in informing and persuading, then under-invest in reminding, generate adoption without retention.
The five stages of the consumer decision-making process map onto these three motives with a precision that makes the architecture clear: Need Recognition → Inform. Information Search → Inform and Persuade. Evaluation of Alternatives → Persuade. Purchase Decision → Persuade. Post-Purchase → Remind.
In life sciences, the 'consumer' is not a single person moving through these five stages in sequence. It is a network of stakeholders — the prescribing physician, the patient, the payer, the formulary committee, the KOL who influences peers — each at a different stage of their own decision-making process simultaneously. The communication strategy must address all of them at their respective stages with messages calibrated to their specific motive and their specific information needs. A single-message strategy that tries to inform, persuade, and remind all stakeholders at once reaches none of them with the precision that drives behavioral change.
Effective Messaging: Seven Principles That Survive the Noise
The content of the message is as consequential as its timing and its medium. Seven principles separate communications that get through from communications that add to the noise:
1. Keep it simple. The message that requires the least cognitive effort to process is the message most likely to survive the noise. Complexity signals effort. In an environment where attention is scarce, the organization that asks for less of it earns more of it.
2. Select the most important benefits and make them the centerpiece. Every product has multiple benefits. The communication that tries to communicate all of them communicates none of them with the emphasis that drives behavior. Choose the one or two benefits that are most meaningful to the specific stakeholder at the specific stage they occupy — and anchor everything there.
3. Emphasize what is fresh and new. Novelty captures attention in a way that familiarity cannot. What is genuinely new about this product, this data, this clinical result — and how does the communication make that newness visible to a stakeholder who has seen many competing claims?
4. Create excitement and grab attention. The communication that generates no emotional response generates no behavioral response. Attention precedes consideration. Consideration precedes adoption. An organization that cannot earn the first cannot achieve either of the others.
5. Differentiate from every available alternative. The communication that sounds like a competitor's communication reinforces the competitor's category as much as the organization's product. The stakeholder's first question — why this, instead of what I already use? — must be answered before any other claim lands.
6. Use words and images that evoke emotion and imagery. Rational arguments inform. Emotional resonance persuades. The physician who remembers a specific patient experience is more likely to prescribe than the physician who remembers a clinical endpoint. The message that connects the clinical evidence to a human experience closes the gap between data and decision.
7. Show how the product fits in their lives. Complex products — those requiring technique, titration, or behavior change — benefit from demonstration over description. Simple products benefit from a tagline that distills the value proposition to its most portable form. The choice between showing and telling is a product characteristic, not a creative preference.
The 6M's Framework: Aligning Every Element of the Communication Strategy
The 6M's framework provides the organizing architecture for a communication strategy in which every element reinforces every other. Misalignment between any two elements produces waste — not the waste of a failed creative execution, but the structural waste of a strategy that pulls in competing directions.
Market. Who is the target stakeholder for this communication, at this stage of their decision-making process? The answer to this question determines everything that follows. A communication strategy that has not precisely defined its market has not begun.
Motives. Why does this stakeholder buy — what need drives the decision, and what motive (Inform, Persuade, or Remind) is appropriate for the stage they currently occupy? The motive defines the purpose of the communication before the message is written.
Message. What must be said, in what form, with what level of complexity, to achieve the communication objective? Message design follows from motive, not from creative preference. A persuasion message that reads like an awareness message fails at both.
Media. Where does this stakeholder seek information, at this stage of their decision-making process? The choice of medium must match where the customer searches, not where the organization prefers to be present. Business-to-business stakeholders in life sciences search differently than consumers. Formulary committees consult health technology assessment bodies and payer publications. Physicians consult peer-reviewed literature, specialty society guidelines, and trusted colleagues. Patients search online and consult patient advocacy communities. Each of these is a distinct media environment with distinct credibility standards.
Money. How much of the communications budget should be allocated to this market, at this stage, through this medium? Three methods for setting the budget: Percentage of Sales allocates based on historical revenue — useful as a baseline, insufficient as a strategy because it does not account for the specific objectives driving the spend. Competitive Parity matches competitor spending — a common practice that assumes the competitor's objectives, resources, and market position are comparable to the organization's, which is rarely true. Objective-and-Task defines the objective, determines the task required to achieve it, and estimates the cost of the task — the only method that builds the budget around what the organization actually needs to accomplish.
Measurement. How will the organization know if the communication worked? The measurement architecture must be defined before the campaign launches, not after. Three levels of measurement are required: company-level KPIs that track overall commercial performance (revenue, market share, customer satisfaction), campaign-level KPIs that track the effectiveness of individual campaigns (awareness, cost per impression, conversion rate), and tactic-level KPIs that track the effectiveness of individual communication tools (content marketing performance, social listening metrics, Net Promoter Score, share of voice).
The 6M's must be aligned. A powerful message delivered through the wrong medium to the wrong market at the wrong stage of the decision-making process produces noise, not adoption.
What the Shift to Bidirectional Communication Actually Means
The transition from unidirectional to bidirectional to social communication is not a media channel evolution. It is a fundamental shift in who controls brand meaning — and it has specific implications for life sciences commercial strategy that many organizations have not yet fully absorbed.
Digital advertising created a feedback loop. Website data — what content consumers engage with, what products they consider, what they ultimately purchase — became the foundation for remarketing, personalization, and campaign optimization. Smart advertising, driven by behavioral data and machine learning, can now identify and reach micro-segments within a target population with message precision that broadcast media cannot approach. The organization that builds its digital intelligence infrastructure before launch has a commercial data asset that compounds in value as the launch progresses.
Social communication created something different: a conversation the organization can observe but not fully control. Physicians discussing clinical experience in online communities. Patients sharing treatment outcomes in patient advocacy forums. Payers publishing formulary decisions and coverage rationales that the market reads and interprets independently of the manufacturer's messaging. In this environment, the organization's promotional investment creates the conditions under which these conversations happen — seeding the evidence, the relationships, and the peer confidence that drive the peer-to-peer communication the organization cannot manufacture.
The practical implication for life sciences communication strategy: the KOL engagement, the advisory board intelligence, the publication planning, the advocacy relations work described in the earlier posts in this series are not pre-launch activities. They are the communication infrastructure on which the launch communication strategy rests. Without them, the message has no amplification network. With them, the organization's communication investment is multiplied by the peer-to-peer conversations it enables.
Measurement as the Accountability Architecture
Of the six M's, measurement is the most consistently under-resourced and the most consequential for long-term commercial performance. An organization that cannot measure the impact of its communication investment cannot improve it — cannot identify which campaigns generated adoption, which messages moved behavior, and which media channels reached the stakeholders who actually changed their prescribing or purchasing decisions as a result.
The discipline of measurement in life sciences communication is complicated by the same stakeholder complexity that complicates every other framework in this series. Attribution — connecting a specific communication to a specific behavioral change — is genuinely difficult when the decision-making process spans months, involves multiple stakeholders, and is mediated by clinical evidence, peer influence, and market access conditions that the promotional budget does not control.
The organizations that navigate this complexity most effectively are the ones that define their measurement architecture before the campaign launches — that establish baseline KPIs at the company, campaign, and tactic levels before any communication is deployed, track those KPIs continuously through the launch, and use the data to reallocate investment in real time toward the channels and messages generating the most measurable response. They treat measurement not as a post-campaign audit but as a continuous optimization discipline.
What nineteen launches demonstrated consistently: the organizations that invested in measurement infrastructure before launch — that defined what success looked like in measurable terms and built the data systems to track it — adapted faster, corrected earlier, and compounded commercial momentum more effectively than those that measured retrospectively. The market gives feedback continuously. The organization that is listening has an advantage the organization that is only broadcasting cannot match.
Measurement is not a post-campaign audit. It is a continuous optimization discipline. The market gives feedback continuously. The organization that is listening has an advantage the organization that is only broadcasting cannot match.
In This Series
Post 1: What 19 Product Launches Taught Me: A Field Guide to Commercial Viability
Post 2: Know Your Customer Better Than They Know Themselves
Post 3: The Price Is the Strategy
Post 4: Getting Through the Noise — You are here.
